This inventor holds 1 USPTO granted patent. Top assignee: Oscient Pharmaceuticals Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Christina Alberti-Segui: Innovator in Polypeptide Research
Introduction
Christina Alberti-Segui is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of novel polypeptides. Her work has implications for therapeutic and diagnostic applications, showcasing her innovative spirit and dedication to scientific advancement.
Latest Patents
Christina holds 1 patent that focuses on polypeptides found on the cell wall of specific organisms. The invention provides methods for utilizing these polypeptides, including the genes encoding them and their fragments, for the preparation of antibodies, vaccines, and other therapeutic and diagnostic compositions.
Career Highlights
Christina is currently associated with Oscient Pharmaceuticals Corporation, where she continues to push the boundaries of research and innovation. Her work at Oscient has positioned her as a key player in the biotechnology sector, contributing to advancements that can lead to significant medical breakthroughs.
Collaborations
Throughout her career, Christina has collaborated with notable colleagues, including Debra A Willins and Arturo Morales. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Christina Alberti-Segui exemplifies the innovative spirit of modern inventors in the biotechnology field. Her contributions to polypeptide research are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile